DRTS
Alpha Tau Medical Ltd · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website alphatau.com
- Employees(FY) 94
- ISIN nan
Performance
+14.57%
1W
+3.51%
1M
-7.52%
3M
-3.41%
6M
-5.98%
YTD
-15.52%
1Y
Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Technical Analysis of DRTS 2024-05-10
Overview:
In analyzing the technical indicators for DRTS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to forecast the possible stock price movement in the upcoming days. By examining these key aspects, we aim to provide a comprehensive and insightful prediction for the future direction of DRTS s...
Recent News & Updates
- 2023-05-23 04:01
- 2023-05-17 04:30
- 2023-05-11 04:00
- 2023-05-03 04:00
- 2023-04-02 21:10
- 2023-03-29 04:00
- 2023-03-11 19:30
- 2023-03-09 03:10
- 2023-03-08 04:00
- 2023-03-02 19:30
- 2023-02-28 19:30
- 2023-02-21 03:00
- 2022-12-12 19:00
- 2022-11-22 03:02
- 2022-11-08 19:00
- 2022-10-21 04:01
- 2022-09-08 04:05
- 2022-09-01 04:15
- 2022-08-30 04:05
- 2022-08-25 04:05
- 2022-08-21 21:00
- 2022-07-05 04:01
- 2022-06-22 04:01
- 2022-06-16 04:01
- 2022-06-07 21:10
- 2022-06-07 04:03
- 2022-05-26 04:05
- 2022-05-22 21:00
- 2022-04-11 22:39
- 2022-03-27 20:00
Page 2 of 2
previousnext